Mckesson recalls
FDA enforcement reports naming Mckesson as the recalling firm.
- Recall reports
- 6
- Class I (serious)
- 1
- Most recent report
- Jul 8, 2026
- Jul 8, 2026Gemcitabine Injection, 1 g per 26Drug · McKessonTemperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.Class II
- Feb 18, 2026UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0Drug · McKessonTemperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environment.Class I
- Feb 5, 2025Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-do…Drug · McKessoncGMP Deviations: Product intended for quarantine was inadvertently distributed.Class II
- Feb 28, 2024CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1Drug · MCKESSON CORPORATIONCGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated.Class II
- Sep 12, 2018Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 c…Drug · Mckesson CorporationSupterpotent DrugClass II
- Oct 15, 2014Amiodarone HCl Injection, 450 mg/9 mL (50 mg per mL), 9 mL Single-Use Vial, Rx only, Ma…Drug · MckessonTemperature Abuse: One shipment was inadvertantly stored refrigerated rather than the labeled room temperature recommendation at McKesson Medical-Surgical Inc., one of the distributing wholesalers.Class II